Series B - Aviir

Series B - Aviir

Investment Firm

Overview

Aviir provides cardio metabolic tests and services for the prevention and management of cardiovascular diseases.

Announced Date

Feb 12, 2013

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a early_stage_venture and private_equity firm.

Participant Investors

4

Investor Name
Participant InvestorMerck Global Health Innovation Fund
Participant InvestorAberdare Ventures
Participant InvestorNew Leaf Venture Partners
Participant InvestorBay City Capital

Round Details and Background

Aviir raised $10000000 on 2013-02-12 in Series B

Aviir provides cardio metabolic tests and services for the prevention and management of cardiovascular diseases.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 20, 2011
Venture Round - Aviir
4-10.0M
Jan 15, 2010
Venture Round - Aviir
3-4.2M
Oct 19, 2009
Venture Round - Aviir
3-1.0M
Sep 20, 2007
Series B - Aviir
3-11.3M

Recent Activity

There is no recent news or activity for this profile.